How to Maximize Retention in Pediatric Trials

Participant retention through the end of a study is a significant challenge for clinical trials involving children. A recent review found that about 20% of pediatric trials fail, often from poor retention due to suboptimal study design and/or implementation.

So, how can we fix these issues affecting pediatric trials?

Hear from our Chief Scientific Officer, Marie Onakomaiya, Ph.D. MPH, and Research Scientist, Abhrajeet (Jeet) Roy, Ph.D., where they will walk you through how to retain and engage participants in pediatric studies, including:

  • Drivers of increased pediatric engagement and compliance
  • How to foster trust and collaboration
  • How to positively reinforce the study journey
  • FDA guidance for pediatric trials

Thank you. Your resource is below.